Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Steroid-Dependent Ulcerative Colitis
NCT00498589Phase 2Completed
- Sponsor
- CHU de Besançon
- Start
- Sep 2007
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial in ulcerative colitis (UC) comparing Methotrexate with Placebo (2 arms). Primary endpoint: Remission without steroids, immunosuppressives and without colectomy at 16 weeks. Started Sep 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00498589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498589.